---
title: Cost-effectiveness of prophylaxis with recombinant versus plasma-derived VWF
  in severe von Willebrand disease in the US
date: '2024-04-18'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38635764/?utm_source=curl&utm_medium=rss&utm_campaign=journals&utm_content=7603509&fc=None&ff=20240419180729&v=2.18.0.post9+e462414
source: Blood
description: We evaluated the cost-effectiveness of prophylaxis with rVWF versus with
  pdVWF for patients with severe VWD. We found that rVWF is a cost-saving factor replacement
  compared to pdVWF across all willingness-to-pay thresholds in the United ...
disable_comments: true
---
We evaluated the cost-effectiveness of prophylaxis with rVWF versus with pdVWF for patients with severe VWD. We found that rVWF is a cost-saving factor replacement compared to pdVWF across all willingness-to-pay thresholds in the United ...